These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 27913547)
21. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management. Michiels JJ; van Vliet HH Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362 [TBL] [Abstract][Full Text] [Related]
22. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings. Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363 [TBL] [Abstract][Full Text] [Related]
23. [Perioperative therapy of von Willebrand disease. Demonstration of pathophysiology, clinical problems and therapy options using two case reports]. Kleinschmidt S; Fuchs-Buder T; Wilhelm W; Seyfert UT; Mörsdorf S Anaesthesist; 2002 Oct; 51(10):825-34. PubMed ID: 12395174 [TBL] [Abstract][Full Text] [Related]
24. Advances in the therapy of von Willebrand disease. Batlle J; Noya MS; Giangrande P; Lopez-Fernandez MF Haemophilia; 2002 May; 8(3):301-7. PubMed ID: 12010427 [TBL] [Abstract][Full Text] [Related]
25. Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment. Castaman G; Federici AB; Rodeghiero F; Mannucci PM Haematologica; 2003 Jan; 88(1):94-108. PubMed ID: 12551832 [TBL] [Abstract][Full Text] [Related]
26. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery. Miesbach W; Berntorp E Eur J Haematol; 2017 Feb; 98(2):121-127. PubMed ID: 27622750 [TBL] [Abstract][Full Text] [Related]
27. Optimizing treatment of von Willebrand disease by using phenotypic and molecular data. Rodeghiero F; Castaman G; Tosetto A Hematology Am Soc Hematol Educ Program; 2009; ():113-23. PubMed ID: 20008189 [TBL] [Abstract][Full Text] [Related]
28. Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients. Federici AB; Bucciarelli P; Castaman G; Baronciani L; Canciani MT; Mazzucconi MG; Morfini M; Rocino A; Schiavoni M; Oliovecchio E; Iorio A; Mannucci PM Semin Thromb Hemost; 2011 Jul; 37(5):511-21. PubMed ID: 22102194 [TBL] [Abstract][Full Text] [Related]
29. Mild forms of von Willebrand disease: diagnosis and management. Federici AB Curr Hematol Rep; 2003 Sep; 2(5):373-80. PubMed ID: 12932308 [TBL] [Abstract][Full Text] [Related]
30. Management of inherited von Willebrand disease in 2007. Federici AB; Mannucci PM Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477 [TBL] [Abstract][Full Text] [Related]
31. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays? Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279 [TBL] [Abstract][Full Text] [Related]
32. Prophylaxis in von Willebrand disease. Franchini M; Targher G; Lippi G Ann Hematol; 2007 Oct; 86(10):699-704. PubMed ID: 17634944 [TBL] [Abstract][Full Text] [Related]
33. Towards novel treatment options in von Willebrand disease. Lenting PJ; Kizlik-Manson C; Casari C Haemophilia; 2022 May; 28 Suppl 4():5-10. PubMed ID: 35521728 [TBL] [Abstract][Full Text] [Related]